FDA Inspection 1162959 — Bora Pharmaceuticals Injectables Inc

Bora Pharmaceuticals Injectables Inc — FEI 1000512361

The FDA completed an inspection of Bora Pharmaceuticals Injectables Inc on February 18, 2022 in Baltimore, MD. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 18, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baltimore, MD (United States)